Yingxue Chen

Yingxue Chen is an accomplished Executive Director in Clinical and Quantitative Pharmacology, currently leading efforts at Ipsen since 2022. They previously served as Executive Director at Epizyme and held various director-level positions at AstraZeneca and Vertex Pharmaceuticals, where they played a pivotal role in the clinical pharmacology of significant drug developments. Earlier in their career, they contributed as a Staff Scientist II at Biogen and an Associate Director at Millennium Pharmaceuticals. Yingxue is also pursuing a post-doctoral degree in Pharmaceutical Sciences with a focus on Pharmacokinetics at The University of Kansas.